MedAvante Research Suggests RBANS is Suitable Neurocognitive Endpoint in MCI Clinical Trials

The RBANS total scale index score correlated with the CDR-SB, and decreased in a linear fashion with increasing CDR-SB, even within a limited range of CDR-SB scores and without evidence of floor or ceiling effects.

Continue reading